Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 03/08/20121 min de lecture
Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT); Public Workshop
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research is announcing a 4-day public workshop entitled "Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT)." The purpose of this workshop is to provide a forum to consider issues related to endpoints that can support drug development in the following disease areas: Eosinophilic esophagitis, pediatric and adult inflammatory bowel disease, and parenteral nutrition-associated liver disease.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →